LFT Results at a Glance

Findings Requiring Attention

1. Elevated Direct (Conjugated) Bilirubin — 0.37 mg/dL (H)

• Mild but flagged as elevated.
• Conjugated hyperbilirubinemia generally indicates hepatocellular damage or biliary obstruction — conditions where bilirubin excretion into bile is impaired and leaks back into serum (Evaluation of Abnormal Liver Chemistries, p. 16).
• Given that total bilirubin is still within normal range and the elevation is very mild, this is a subtle early signal rather than overt disease. Causes to consider:
  • Early intrahepatic cholestasis (e.g., fatty liver, medication effect)
  • Gilbert syndrome variant (though more commonly indirect)
  • Biliary pathology at a subclinical level

2. Markedly Elevated Albumin — 6.41 g/dL (Normal: 3.97–4.94)

• This is significantly above normal and unusual. Clinically, hypoalbuminemia (low albumin) is the common concern in liver disease. Hyperalbuminemia of this degree is almost always a laboratory artifact or error rather than a true clinical finding.
• Most likely explanations:
  • Severe dehydration / hemoconcentration — the most common real cause, concentrating all serum proteins
  • Lab error (sample mix-up, analyzer calibration issue, use of BCG method with interfering substances)
  • Very rarely, anabolic steroid use or IV albumin infusion

3. Very Low Globulin — 0.91 g/dL (Normal: 1.90–3.70)

• Globulin is a calculated value: Total Protein − Albumin = 7.32 − 6.41 = 0.91.
• If albumin is spuriously elevated, globulin will be spuriously depressed — this directly explains the low globulin and the sky-high A/G ratio of 7.04.
• True hypo-globulinemia (if albumin is genuinely high) could indicate immunodeficiency, but this is far less likely than an albumin measurement error.

4. AST/ALT Ratio of 1.22

• A ratio >1 (particularly >2) is associated with alcoholic liver disease. A ratio of 1.22 is borderline but not diagnostic on its own.
• Both AST (46.80) and ALT (38.40) are within normal limits but both are in the upper third of their ranges, which warrants monitoring.

Summary Interpretation

Recommended Next Steps

1. Repeat fasting LFT with adequate hydration to confirm albumin/globulin values.
2. Urine bilirubin test — if positive, confirms conjugated hyperbilirubinemia.
3. Ultrasound abdomen — to evaluate for fatty liver, gallstones, biliary dilation, or hepatomegaly.
4. Additional workup if enzymes remain elevated: GGT, fasting lipid profile, HBsAg, anti-HCV.
5. Correlate clinically — any history of alcohol use, medications, recent fasting, or systemic illness is important.

⚠️ Note: This interpretation is for informational purposes only. Please consult a physician or hepatologist for clinical evaluation and management decisions.

Management Plan for Kaushik Saha (58M)

Step 1 — Immediate: Confirm Results Before Treating

• Repeat fasting LFT with good hydration
• Ensure sample is collected correctly (non-hemolyzed, no IV line contamination)
• This single step may resolve most of the "abnormal" findings

Step 2 — Investigate the Mild Conjugated Hyperbilirubinemia

Step 3 — Address the Borderline Liver Enzymes (AST 46.80, ALT 38.40)

Lifestyle Modifications (First-line, regardless of cause):

• Weight management — even 5–10% body weight loss significantly reduces liver fat and enzyme levels
• Diet:
  • Reduce refined carbohydrates, sugars, and saturated fats
  • Mediterranean diet is the most evidence-backed for liver health
  • Avoid alcohol entirely or minimize significantly
• Exercise: At least 150 minutes/week of moderate aerobic activity; resistance training also beneficial
• Medication review: Stop or substitute any hepatotoxic drugs (statins, NSAIDs, herbal supplements)

Step 4 — Monitoring Plan

When to Refer to a Hepatologist Urgently

• Jaundice, dark urine, pale stools
• Abdominal pain or distension
• Significant rise in bilirubin, AST, or ALT on repeat testing
• Evidence of biliary dilation on ultrasound
• Positive viral hepatitis markers

Key Takeaway

1. Repeat LFT to confirm results
2. Ultrasound + targeted bloodwork to find the cause of mild conjugated hyperbilirubinemia
3. Immediate lifestyle changes for upper-normal liver enzymes
4. Close monitoring over 3–6 months

⚠️ This guidance is educational. A physician must evaluate the full clinical picture — symptoms, examination, medications, and comorbidities — before finalizing management.